Farag, Mohamed
Spinthakis, Nikolaos
Gorog, Diana A
Prasad, Abhiram
Sullivan, Keith
Akhtar, Zaki
Kukreja, Neville
Srinivasan, Manivannan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Stable coronary artery disease: revascularisation and invasive strategies
https://doi.org/10.1016/s0140-6736(15)61220-x
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis
https://doi.org/10.1016/s0140-6736(15)01039-9
Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease
https://doi.org/10.1136/openhrt-2016-000462
Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis
https://doi.org/10.1136/heartjnl-2016-310886
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
https://doi.org/10.1016/s0140-6736(15)00979-4
Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial
https://doi.org/10.1016/j.ahj.2015.07.013